Skip to main content

Table 4 Results of this analysis

From: Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis

Outcomes analyzed OR with 95% CI P value I2 (%)
Any bleeding
Intra-cranial bleeding
Gastrointestinal bleeding
Stroke/SE/TIA
Venous thromboembolism
Mortality
1.28 [0.95–1.72]
2.18 [0.51–9.25]
0.98 [0.43–2.25]
0.81 [0.53–1.23]
2.06 [0.73–5.82]
1.42 [0.99–2.06]
0.11
0.29
0.97
0.32
0.17
0.06
0
0
0
0
0
38
  1. Abbreviations: SE systemic embolism, TIA transient ischemic attack, OR odds ratios, CI confidence interval